Australia markets close in 24 minutes

ReNeuron Group plc (RNUGF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.0007-0.0498 (-98.62%)
At close: 09:30AM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/03/2023
31/03/2022
31/03/2021
31/03/2020
Total revenue
249
530
403
257
6,065
Operating expenses
Research development
3,654
4,463
8,068
9,503
11,580
Selling general and administrative
686
1,132
1,127
1,409
1,914
Total operating expenses
6,390
7,645
11,628
13,247
20,574
Operating income or loss
-6,141
-7,115
-11,225
-12,990
-14,509
Interest expense
18
20
25
32
42
Income before tax
-6,067
-6,657
-11,058
-13,410
-13,858
Income tax expense
-994
-1,249
-1,369
-2,063
-2,446
Income from continuing operations
-5,073
-5,408
-9,689
-11,347
-11,412
Net income
-5,073
-5,408
-9,689
-11,347
-11,412
Net income available to common shareholders
-5,073
-5,408
-9,689
-11,347
-11,412
Basic EPS
-0.09
-0.10
-0.17
-0.29
-0.36
Diluted EPS
-0.09
-0.10
-0.17
-0.29
-0.36
Basic average shares
57,168
57,126
56,976
39,129
31,811
Diluted average shares
57,168
57,126
56,976
39,129
31,811